# Early alcohol abstinence symptoms and the role of cumulative adversity

## TL;DR

This study found that people with alcohol use disorder and more lifetime adversity experience more severe early abstinence symptoms during treatment.

## Contribution

The study shows cumulative lifetime adversity moderates the severity of early alcohol abstinence symptoms.

## Key findings

- Abstinence symptoms decreased by week 3 for all participants.
- Higher lifetime adversity correlated with more severe symptoms at treatment admission.
- Cumulative adversity may predict treatment outcomes and guide personalized care.

## Abstract

This study examined the course of early alcohol abstinence symptoms across multiple clinical domains (i.e., cravings, withdrawal, mood, and cardiovascular measures) in individuals undergoing inpatient alcohol treatment and assessed whether cumulative lifetime adversity influences the severity and trajectory of these symptoms.

Researchers tracked withdrawal symptoms, alcohol cravings, mood states, heart rate, and blood pressure in 34 inpatient participants at treatment admission and weekly for three to four consecutive weeks. The analysis employed two approaches: first, examining symptom presentation and progression over time in alcohol‐dependent individuals using cumulative adversity as a moderating variable; second, comparing symptom patterns between alcohol‐dependent participants with high versus low lifetime adversity against 38 control participants at each timepoint.

Abstinence symptoms resolved by the third week of inpatient treatment across all participants. However, alcohol‐dependent individuals with greater lifetime adversity exhibited significantly more severe symptom patterns compared to alcohol‐dependent individuals with fewer adverse experiences. These differences persisted even when controlling for recent alcohol and tobacco use severity over the preceding 3 months.

Understanding the profile and progression of early abstinence symptoms, along with stress‐related moderating factors, could inform more personalized care planning. Cumulative lifetime adversity may serve as a readily measurable correlate of early abstinence severity and may be valuable for predicting alcohol treatment outcomes. Addressing the effects of cumulative lifetime adversity may serve as a target for early intervention in patients with alcohol use disorder.

Objectives were to characterize early alcohol abstinence symptoms during inpatient treatment, and examine the role of cumulative lifetime adversity in moderating these symptoms. A decrease in alcohol craving, anxiety, and depression was observed in all participants by week 3 of treatment. A more severe abstinence profile was seen in individuals with higher adversity, particularly on admission to treatment. As elevations in these clinical symptoms on treatment entry can predict treatment success, cumulative adversity may represent a key indicator of risk.